logotype
  • Week's top
  • Latest news
  • Unread news
  • Subscribe

Science X Account

Sign in with

Forget Password?

Not a member? Sign up

Learn more

  • Addiction
  • Alzheimer's disease & dementia
  • Arthritis & Rheumatism
  • Attention deficit disorders
  • Autism spectrum disorders
  • Biomedical technology
  • Cardiology
  • Dentistry
  • Diabetes
  • Diseases, Conditions, Syndromes
  • Endocrinology & Metabolism
  • Gastroenterology
  • Genetics
  • Gerontology & Geriatrics
  • Health
  • Health informatics
  • HIV & AIDS
  • Immunology
  • Inflammatory disorders
  • Medical economics
  • Medical research
  • Medications
  • Neuroscience
  • Obstetrics & gynaecology
  • Oncology & Cancer
  • Ophthalmology
  • Other
  • Overweight & Obesity
  • Parkinson's & Movement disorders
  • Pediatrics
  • Psychology & Psychiatry
  • Radiology & Imaging
  • Sleep disorders
  • Sports medicine & Kinesiology
  • Surgery
  • Vaccination
  • Asthma
  • Breast cancer
  • Cardiovascular disease
  • Chronic obstructive pulmonary disease
  • Colon cancer
  • Coronary artery disease
  • Dementia
  • Depression
  • Heart attack
  • Heart disease
  • High blood pressure
  • Influenza
  • Kidney disease
  • Leukemia
  • Lung cancer
  • Malaria
  • Melanoma
  • Multiple sclerosis
  • Myocardial infarction
  • Ovarian cancer
  • Post traumatic stress disorder
  • Rheumatoid arthritis
  • Schizophrenia
  • Skin cancer
  • Stroke
  • Type 2 diabetes
  • Full List »
  1. Home
  2. Archive
  3. 19/11/2017

Archive: 19/11/2017

Psychosocial benefit seen with probiotic, peanut oral immunotx

(HealthDay)—Probiotic and peanut oral immunotherapy (PPOIT) has a sustained beneficial effect on psychosocial impact of food allergy after end-of-treatment, according to a study published online Oct. 20 in Allergy.

Nov 19, 2017

0

1

Higher positive end-expiratory pressure no benefit in ARDS

(HealthDay)—For patients with acute respiratory distress syndrome (ARDS), higher positive end-expiratory pressure (PEEP) levels are not likely to improve clinical outcomes, according to a review published in the October ...

Nov 19, 2017

0

9

Allopurinol has little benefit in cardiac syndrome X

(HealthDay)—Allopurinol does not appear to improve exercise capacity or peripheral endothelial or coronary function in patients with cardiac syndrome X, according to a study published online Oct. 28 in Cardiovascular Therapeutics.

Nov 19, 2017

0

0

Erlotinib overdose tied to conjunctivitis

(HealthDay)—Overdosing of erlotinib may be associated with rapid onset of conjunctivitis, according to a case report published online Oct. 25 in the Journal of Clinical Pharmacy and Therapeutics.

Nov 19, 2017

0

0

What it takes to get teens moving

(HealthDay)—Teens with friends are active teens, a new study suggests.

Nov 19, 2017

0

1

page 2 from 2
  • «
  • »
Phys.org

Phys.org

Daily science news on research developments and the latest scientific innovations

Tech Xplore

Tech Xplore

The latest engineering, electronics and technology advances

ScienceX

Science X

The most comprehensive sci-tech news coverage on the web

Newsletters

Science X Daily and the Weekly Email Newsletter are free features that allow you to receive your favorite sci-tech news updates in your email inbox

Follow us

  • Top
  • Home
  • Search
  • Mobile version
  • Help
  • FAQ
  • About
  • Contact
  • Science X Account
  • Premium Account
  • Newsletter
  • Archive
  • Android app
  • iOS app
  • RSS feeds
  • Push notification
© Medical Xpress 2011 - 2025 powered by Science X Network
Privacy policy Terms of use Medical Disclaimer

E-mail newsletter

Follow us